Loading…
The Gabelli Healthcare & Wellness Trust is projected to rise to $12.23 by 2027, a +27% move from its current price of $9.60. GRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $9.54 | $9.61 | $9.67 | +0.08% |
| Jul 13 | $9.52 | $9.62 | $9.71 | +0.16% |
| Jul 14 | $9.51 | $9.62 | $9.74 | +0.24% |
| Jul 15 | $9.50 | $9.63 | $9.76 | +0.33% |
| Jul 16 | $9.50 | $9.64 | $9.78 | +0.41% |
| Jul 17 | $9.49 | $9.65 | $9.81 | +0.49% |
| Jul 18 | $9.48 | $9.65 | $9.83 | +0.57% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.48 | $9.65 | $9.83 | +0.57% |
| Week 2 | $9.47 | $9.71 | $9.96 | +1.15% |
| Week 3 | $9.47 | $9.77 | $10.07 | +1.72% |
| Week 4 | $9.48 | $9.82 | $10.18 | +2.30% |
| Week 5 | $9.49 | $9.88 | $10.28 | +2.89% |
| Week 6 | $9.51 | $9.93 | $10.38 | +3.48% |
| Week 7 | $9.53 | $9.99 | $10.47 | +4.07% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
The Gabelli Healthcare & Wellness Trust (GRX) is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe and seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector.
It invests in stocks of companies across all market capitalizations and benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.
GRX is a closed-ended equity mutual fund with a current price of $9.66 and a market cap of $145.39M, ranking 3931. It operates within the Financial Services category.
The forecast presents the current price journey and outlook, with 2026 showing an average of $9.66 and a max of $13.10 (sentiment NEUTRAL). From 2027 onward, the outlook is bullish with rising averages and ROIs, culminating in a 2050 average of $70.23 and a max of $114.86 (ROI 627.1).
In the near term, the 30-day range is $9.19 to $10.15, with price dynamics influenced by a resistance at $9.66 and a support at $8.87.
A major floor 10.8% below — a decisive break under it would weaken the trend.
The nearest floor, 7.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.9% away) — a breakout level to watch.
A major ceiling 6.3% above — clearing it would confirm fresh momentum.
Key GRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.63 | Sell | $9.60 | Buy |
| MA 10 | $9.55 | Buy | $9.52 | Buy |
| MA 20 | $9.31 | Buy | $9.39 | Buy |
| MA 50 | $9.14 | Buy | $9.25 | Buy |
| MA 100 | $9.26 | Buy | $9.27 | Buy |
| MA 200 | $9.36 | Buy | $9.35 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 68.02 | Neutral |
| Stoch RSI (14) | 74.11 | Neutral |
| CCI (20) | 81.32 | Neutral |
| Williams %R (14) | -12.50 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 5.73 | Buy |
| Bollinger %B (20,2) | 0.77 | Neutral |
| Stochastic %K (14) | 87.50 | Sell |
| TRIX (15) | 0.19 | Buy |
| Awesome (5,34) | 0.43 | Buy |
| Ultimate (7,14,28) | 74.87 | Sell |
| Momentum (10) | 0.33 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 9.65 | Sell |
| ADX (14) | 28.12 | Buy |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is mixed, with sentiment listed as NEUTRAL. The RSI(14) is 80, indicating elevated momentum, while the SMA50 is $9.10 and the SMA200 is $9.35.
Price is trading in proximity to resistance at $9.66, with support at $8.87. The 30-day trading range spans from $9.19 to $10.15, framing near-term volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.87 | $9.60 | $12.91 | 0% | Neutral | |
| $10.02 | $12.23 | $15.61 | +27% | Bullish | |
| $10.25 | $12.76 | $16.73 | +33% | Bullish | |
| $11.53 | $14.56 | $19.50 | +52% | Bullish | |
| $11.85 | $15.17 | $20.68 | +58% | Bullish | |
| $12.01 | $15.56 | $21.55 | +62% | Bullish | |
| $14.59 | $19.12 | $26.86 | +99% | Bullish | |
| $16.85 | $22.32 | $31.75 | +133% | Bullish | |
| $18.00 | $24.07 | $34.65 | +151% | Bullish | |
| $18.84 | $25.43 | $37.02 | +165% | Bullish | |
| $27.86 | $39.24 | $59.85 | +309% | Bullish | |
| $45.63 | $68.91 | $112.67 | +618% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $8.87 | $9.60 | $11.39 | +0.00% |
| August 2026 | $8.45 | $9.89 | $11.83 | +3.02% |
| September 2026 | $8.79 | $10.34 | $12.46 | +4.54% |
| October 2026 | $8.84 | $10.44 | $12.67 | +1.01% |
| November 2026 | $8.73 | $10.34 | $12.62 | -0.96% |
| December 2026 | $8.85 | $10.53 | $12.91 | +1.77% |
Click any year to see its month-by-month GRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The GRX price prediction for 2026 points to an average of $9.60 (low $8.87, high $12.91) — a potential gain of 0% on today's $9.60. Price action looks broadly range-bound.
In 2027, GRX is projected to trade between $10.02 and $15.61, averaging $12.23 — a potential gain of +27% from today's $9.60. That is up +27% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The Gabelli Healthcare & Wellness Trust's 2028 outlook centres on $12.76, within a $10.25 to $16.73 range. That is up +4% on the projected 2027 average. That marks a +33% change versus current levels. Momentum favours further upside here.
By 2029, GRX could reach as high as $19.50, with a base case around $14.56 and support toward $11.53 — roughly +52% from $9.60. Buyers look set to stay in control over this stretch.
Expect GRX to range from $11.85 to $20.68 through 2030. The $15.17 average target implies a +58% move from current prices. That is up +4% on the projected 2029 average. Momentum favours further upside here.
The GRX price prediction for 2031 points to an average of $15.56 (low $12.01, high $21.55) — a potential gain of +62% on today's $9.60. Buyers look set to stay in control over this stretch.
In 2032, GRX is projected to trade between $14.59 and $26.86, averaging $19.12 — a potential gain of +99% from today's $9.60. That is up +23% on the projected 2031 average. Momentum favours further upside here.
The Gabelli Healthcare & Wellness Trust's 2033 outlook centres on $22.32, within a $16.85 to $31.75 range. That is up +17% on the projected 2032 average. That marks a +133% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, GRX could reach as high as $34.65, with a base case around $24.07 and support toward $18.00 — roughly +151% from $9.60. Momentum favours further upside here.
Expect GRX to range from $18.84 to $37.02 through 2035. The $25.43 average target implies a +165% move from current prices. That is up +6% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The GRX price prediction for 2040 points to an average of $39.24 (low $27.86, high $59.85) — a potential gain of +309% on today's $9.60. Momentum favours further upside here.
In 2050, GRX is projected to trade between $45.63 and $112.67, averaging $68.91 — a potential gain of +618% from today's $9.60. That is up +76% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in GRX today (≈ 104.166667 GRX) could be worth
$7,177.87
+$6,177.87 (+618%) by 2050 · US Dollar
Based on the average projected GRX price of $68.91 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GRXwould be worth at today's price.
$1,000 invested in GRX on Jul 10, 2025 (≈ 105.596618 GRX) would be worth
$1,013.73
+$13.73 (+1.4%) today · 1.01× · US Dollar
Based on a GRX entry price of $9.47 vs. today's $9.6.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.66 | $993.79 | -0.6% |
| 1 month ago | $9.16 | $1,048.03 | +4.8% |
| 3 months ago | $9.19 | $1,044.61 | +4.5% |
| 6 months ago | $9.57 | $1,003.13 | +0.3% |
| 1 year ago | $9.47 | $1,013.73 | +1.4% |
| All time (5.0y) ago | $13.6 | $705.88 | -29.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GRX forecast.
Our base-case forecast reaches $19.00 around 2032.
Implied market cap at $19.00: $280.66M
The multi-year forecast shows a bullish trajectory beginning in the later years. For 2026 the min is $8.87, the avg is $9.66, the max is $13.10, with ROI 0 and sentiment NEUTRAL. In 2027 the avg is $12.31 with a max of $15.73 and ROI 27.4, followed by 2028 avg $12.89 (max $16.91, ROI 33.4) and 2029 avg $14.80 (max $19.83, ROI 53.2).
Further years ascend rapidly: 2030 avg $15.26 (max $20.81, ROI 58), 2031 avg $15.71 (max $21.76, ROI 62.7), 2032 avg $19.61 (max $27.55, ROI 103), 2033 avg $22.58 (max $32.13, ROI 133.8), 2034 avg $24.29 (max $34.98, ROI 151.4), 2035 avg $25.98 (max $37.83, ROI 169).
The forecast extends to 2040 with avg $39.99 (max $61.02, ROI 314) and to 2050 with avg $70.23 (max $114.86, ROI 627.1). These figures illustrate a strong upward trajectory under the stated assumptions, but they are estimates, not guarantees, and are subject to market conditions.
Tap a question to reveal the answer.
In 2030, the forecast shows an avg of $15.26 with a min of $11.92 and a max of $20.81, yielding an ROI of 58 and a bullish sentiment.
Forecasts indicate a bullish sentiment from 2027 onward with rising averages and ROIs (e.g., 2027 avg $12.31, ROI 27.4; 2028 avg $12.89, ROI 33.4; 2050 avg $70.23, ROI 627.1). The 2026 outlook is neutral (avg $9.66, max $13.10). These are estimates, not guarantees.
Yes. The forecast lists a max of $20.81 in 2030.
The current price is $9.66.
The 30-day range is $9.19 to $10.15.
The Gabelli Healthcare & Wellness Trust Community Discussion
0Share your The Gabelli Healthcare & Wellness Trust price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.